For: | Tomizawa M, Saisho H. Signaling pathway of insulin-like growth factor-II as a target of molecular therapy for hepatoblastoma. World J Gastroenterol 2006; 12(40): 6531-6535 [PMID: 17072986 DOI: 10.3748/wjg.v12.i40.6531] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i40/6531.htm |
Number | Citing Articles |
1 |
Ling Fan, Jintong Na, Tieliu Shi, Yuan Liao. Hepatoblastoma: From Molecular Mechanisms to Therapeutic Strategies. Current Oncology 2025; 32(3): 149 doi: 10.3390/curroncol32030149
|
2 |
Wolfgang Hartmann, Jan Küchler, Arend Koch, Nicolaus Friedrichs, Anke Waha, Elmar Endl, Jacqueline Czerwitzki, Dagmar Metzger, Susanne Steiner, Peter Wurst, Ivo Leuschner, Dietrich von Schweinitz, Reinhard Buettner, Torsten Pietsch. Activation of Phosphatidylinositol-3′-kinase/AKT Signaling Is Essential in Hepatoblastoma Survival. Clinical Cancer Research 2009; 15(14): 4538 doi: 10.1158/1078-0432.CCR-08-2878
|
3 |
Rajkumar Venkatramani, Wayne L. Furman, Joerg Fuchs, Steven W. Warmann, Marcio H. Malogolowkin. Current and Future Management Strategies for Relapsed or Progressive Hepatoblastoma. Pediatric Drugs 2012; 14(4): 221 doi: 10.2165/11597740-000000000-00000
|
4 |
Garima Upreti, Regi Thomas, Sharon Milton, Rajan Sundaresan. Bilateral juvenile nasopharyngeal angiofibroma with hepatoblastoma and horseshoe kidney: Implication of common molecular signaling?. International Forum of Allergy & Rhinology 2023; 13(1): 96 doi: 10.1002/alr.23038
|
5 |
Minoru Tomizawa, Fuminobu Shinozaki, Takao Sugiyama, Shigenori Yamamoto, Makoto Sueishi, Takanobu Yoshida. Insulin‐Like growth factor I receptor involvement in proliferation of NOR‐P1 cells in serum‐free media. Journal of Cellular Biochemistry 2012; 113(8): 2714 doi: 10.1002/jcb.24149
|
6 |
Dolores López-Terrada, Preethi H. Gunaratne, Adekunle M. Adesina, Joseph Pulliam, David M. Hoang, Yummy Nguyen, Toni-Ann Mistretta, Judith Margolin, Milton J. Finegold. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Human Pathology 2009; 40(6): 783 doi: 10.1016/j.humpath.2008.07.022
|
7 |
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, MAKOTO SUEISHI. Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells. Oncology Letters 2014; 8(5): 2023 doi: 10.3892/ol.2014.2484
|
8 |
Dolores H. López-Terrada. Hepatoblastoma. Diagnostic Histopathology 2014; 20(2): 67 doi: 10.1016/j.mpdhp.2014.01.002
|
9 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_22-1
|
10 |
Yihui Chen, Wei Zhong, Baohua Chen, Chuanyu Yang, Song Zhou, Jing Liu. Effect of curcumin on vascular endothelial growth factor in hypoxic HepG2 cells via the insulin‑like growth factor 1 receptor signaling pathway. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5783
|
11 |
|
12 |
O. Nedić, V. Malenković, B. Đukanović, I. Baričević. Association of Elevated IGFBP-1 with Increased IGF-II Concentration in Patients with Carcinoma of the Liver. The International Journal of Biological Markers 2008; 23(4): 225 doi: 10.1177/172460080802300405
|
13 |
Michael A. Nalesnik, Tong Wu, Eizaburo Sasatomi, Anthony J. Demetris. Hepatocellular Carcinoma. 2009; : 183 doi: 10.1007/978-1-60327-376-3_6
|
14 |
Piotr Czauderna, Dolores Lopez-Terrada, Eiso Hiyama, Beate Häberle, Marcio H. Malogolowkin, Rebecka L. Meyers. Hepatoblastoma state of the art. Current Opinion in Pediatrics 2014; 26(1): 19 doi: 10.1097/MOP.0000000000000046
|
15 |
R Vasilcanu, D Vasilcanu, L Rosengren, N Natalishvili, B Sehat, S Yin, A Girnita, M Axelson, L Girnita, O Larsson. Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1. Oncogene 2008; 27(11): 1629 doi: 10.1038/sj.onc.1210797
|
16 |
Jeng-Eing Jeng, Lea-Yea Chuang, Wang-Lung Chuang, Jan-Gowth Chang, Jung-Fa Tsai. Insulin-Like Growth Factor II in Hepatocellular Carcinoma. Biomarkers in Medicine 2007; 1(2): 261 doi: 10.2217/17520363.1.2.261
|
17 |
Sonja E Steigen, David F Schaeffer, Robert B West, Torsten O Nielsen. Expression of insulin-like growth factor 2 in mesenchymal neoplasms. Modern Pathology 2009; 22(7): 914 doi: 10.1038/modpathol.2009.48
|
18 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 411 doi: 10.1007/978-3-319-26956-6_22
|
19 |
Arthur Zimmermann, Dolores Lopez-Terrada. Pediatric Liver Tumors. Pediatric Oncology 2011; : 83 doi: 10.1007/978-3-642-14504-9_9
|
20 |
Tanja Nussbaum, Jana Samarin, Volker Ehemann, Michaela Bissinger, Eduard Ryschich, Akmal Khamidjanov, Xiaolei Yu, Norbert Gretz, Peter Schirmacher, Kai Breuhahn. Autocrine insulin‐like growth factor‐II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis†‡. Hepatology 2008; 48(1): 146 doi: 10.1002/hep.22297
|
21 |
Angélica Rossi Sartori-Cintra, Cristiane Sampaio de Mara, Danielle L. Argolo, Ibsen Bellini Coimbra. Regulation of hypoxia-inducible factor-1α (HIF-1α) expression by interleukin-1β (IL-1β), insulin-like growth factors I (IGF-I) and II (IGF-II) in human osteoarthritic chondrocytes. Clinics 2012; 67(1): 35 doi: 10.6061/clinics/2012(01)06
|